Buying Education
How to choose a test kit
What the label is really telling you, what a result can and cannot show, and the questions worth asking before you buy.
Buying a kit is optional
The random scheduling and accountability service is free. Test kits and any laboratory testing are purchased separately. You never need to buy a kit to use the free schedule. P in the Cup does not sell or administer tests, and we currently do not earn affiliate commissions.
Home tests are screening tests
Home tests are screening tests. A preliminary positive should be confirmed by an appropriate laboratory test before serious action is taken. A negative result does not rule out substance use. Follow the exact test instructions and consult a healthcare professional about interpretation.
Source: U.S. Food and Drug Administration, "Drugs of Abuse Home Use Test".
Panels are not the same as substances
A "panel" is one test on the device, usually for one drug or one drug class. A 5-panel or 12-panel test runs five or twelve of those tests. The number tells you how many things are tested, not which ones. Two 12-panel kits can test for different substances.
- Read the list of substances printed on the package or in the instructions. That list is what the test covers. Anything not on it is not tested.
- A higher panel count does not mean "everything". No home panel tests for every substance.
- Fentanyl and other synthetic opioids may not be included unless they are listed. A test labelled "opiates" is not the same as a test for fentanyl.
This matters in practice. A 2020 CDC report from a Baltimore emergency department drug surveillance system found that the hospital's opiate screen was negative for 55% (186 of 340) of the specimens that were positive for fentanyl. If fentanyl matters to your agreement, look for a test that names it.
MedlinePlus (from the U.S. National Library of Medicine) also notes that some medicines, and poppy seeds, can show up as opioids on test results.
Cutoffs and units
Each panel has a cutoff: a threshold amount. A test reads positive only when the amount detected reaches that threshold. Below it, the test reads negative, even if a small amount is present.
MedlinePlus explains a negative opioid test the same way: it can mean no opioids were found, or that only a very small amount was found, too little to be called positive.
- Find the cutoff for each substance in the package insert or instructions for use.
- Check the unit the cutoff is written in. Only compare cutoffs between kits when the units match.
- Kits with different cutoffs for the same substance can give different results on the same sample.
We do not quote cutoff values here. The right source for a cutoff is the exact product's own instructions.
Specimen types and detection windows
Drug tests can use urine, saliva (oral fluid), hair, blood or sweat. Most home tests use urine; MedlinePlus says most opioid tests require a urine sample. FDA notes that it takes time for drugs to appear in urine, hair, saliva or other samples, so a test taken too early, or too late, can miss use. MedlinePlus adds that hair can show longer-term use.
FDA publishes the general guideline below for urine home tests. FDA presents these as guidelines only: detection times vary with how long and how much a drug was used and with each person's metabolism.
| Drug | Positive test soon after use | Positive test may continue for |
|---|---|---|
| Marijuana | 1–3 hours | 1–7 days |
| Cocaine | 2–6 hours | 2–3 days |
| Heroin (opiates) | 2–6 hours | 1–3 days |
| Amphetamine, methamphetamine | 4–6 hours | 2–3 days |
| PCP | 4–6 hours | 7–14 days |
| Ecstasy | 2–7 hours | 2–4 days |
| Benzodiazepines | 2–7 hours | 1–4 days |
| Barbiturates | 2–4 hours | 1–3 weeks |
| Methadone | 3–8 hours | 1–3 days |
| Tricyclic antidepressants | 8–12 hours | 2–7 days |
| Oxycodone | 1–3 hours | 1–2 days |
Source: FDA, "Drugs of Abuse Home Use Test" (content current as of 27 September 2018). FDA's table does not include fentanyl. These are general guidelines, not a prediction for any person, and do not apply to other specimen types.
Home-use and professional-use labelling
The labelling says who a test is intended for. FDA reviews many drugs of abuse tests before they are sold, including their design, performance and instructions. FDA lists example tests by setting: urine tests for over-the-counter (home) use, for doctors' offices and drug treatment centres, and for laboratories; oral-fluid tests for laboratory and workplace settings.
FDA also says that tests intended only for employment and insurance testing are generally not reviewed by FDA, as long as the labelling says the device is intended solely for that use. So "for employment and insurance testing only" on a package is a meaningful statement, not small print. FDA also notes that the same test is sometimes sold under different brand names.
FDA "cleared" versus "approved"
These words mean different things for medical devices, including test kits.
- Cleared refers to a 510(k) premarket notification. FDA describes a 510(k) as a submission showing that a device is as safe and effective as, that is, substantially equivalent to, a device already legally on the market.
- Approved refers to Premarket Approval (PMA), which FDA calls the most stringent type of device marketing application. It is based on FDA's determination that there is sufficient valid scientific evidence of safety and effectiveness.
FDA's drugs of abuse tests page lists the common test types as Class II devices and describes its published decision summaries as being for tests "cleared by the FDA for marketing". If a seller describes a drug test kit as "FDA approved", ask which FDA record supports that, and check it. FDA's drugs of abuse tests page links to its public databases.
Neither word is a guarantee of a correct result for every sample. They describe a regulatory decision, not a promise.
What "CLIA-waived" means, and what it does not
CLIA (the Clinical Laboratory Improvement Amendments of 1988) is about the quality of laboratory testing. CMS regulates laboratory testing performed on humans in the U.S. and issues laboratory certificates; FDA categorises tests by complexity; CDC provides research and technical support.
FDA places tests in one of three categories: waived, moderate complexity or high complexity. Waived tests are, in the words of the law FDA quotes, "simple laboratory examinations and procedures that have an insignificant risk of an erroneous result". A waived test may be performed by laboratories that hold a Certificate of Waiver.
FDA says tests cleared or approved for home use are categorised as waived. The reverse is not true: a test can become waived without being cleared for home use, for example when a manufacturer of a moderate-complexity test applies for a waiver. So "CLIA-waived" on its own tells you about laboratory categorisation. It does not by itself mean a test is cleared or approved for home use. Check the intended use in the instructions.
Read the package insert first
The package insert, or instructions for use, is the most important document for any kit. FDA says it is very important that the person doing the test reads and understands the instructions before collecting the sample, because the result must be read visually within a certain number of minutes after the test starts.
- Read window: read the result at the time the instructions give. FDA says the result must be read within a certain number of minutes after the test starts, so plan for that before you begin.
- Storage: store the kit as the instructions say. FDA lists chemicals that went bad from incorrect storage as one reason a test can give a wrong negative.
- Expiry: check the expiration date before use. FDA also lists tests used after their expiration date as a reason for a wrong negative.
- Substances and cutoffs: confirm the list and cutoffs match what your agreement covers.
- Intended use: check that the insert says the test is for home use if that is how you will use it.
What "presumptive positive" and "negative" mean
Home tests are qualitative: they show whether a particular drug may be present, not how much.
Presumptive (preliminary) positive
A positive home result is preliminary, not proof. FDA says foods, supplements, beverages and medicines can affect results, and that some over-the-counter medicines can give the same result as amphetamines. A positive for a prescribed medicine does not on its own mean the medicine is being misused. FDA's advice is to send the sample to a laboratory for a second test and to take no serious actions until you have the laboratory's result.
Negative
A negative applies only to the substances tested, at the kit's cutoffs, within its detection windows. FDA says no drug test of this type is 100% accurate, and a negative can happen if the test looked for the wrong drug, the sample was collected too early or too late, or the test was stored incorrectly or out of date. FDA notes that you can test again later.
Why laboratory confirmation matters
FDA calls laboratory tests the most reliable way to confirm drugs of abuse. Laboratories do a preliminary analysis and, if it is positive, a more complete analysis of the sample. Federal workplace testing, which SAMHSA oversees, also has results reviewed by a Medical Review Officer, a licensed physician, and SAMHSA notes that even a laboratory-confirmed positive does not automatically mean someone misused drugs. In a personal agreement, that is a good reason to treat any result calmly and to agree in advance what happens after a preliminary positive.
Checklist
Questions to ask before buying
- Which exact substances does it test for, and are they the ones in our agreement?
- If fentanyl or another synthetic opioid matters to us, is it named on the label?
- What is the cutoff for each substance, and in what unit?
- What specimen does it use, and does that fit our timing?
- Does the instructions for use say it is intended for home use?
- Can the seller point to an FDA record for this exact test? Does it say "cleared", and does that match?
- Is it labelled "for employment and insurance testing only"?
- How long is the read window, and can we follow it reliably?
- How should it be stored, and when does it expire?
- What is the cost per test, not just per pack?
- How would we get laboratory confirmation after a preliminary positive, and what would it cost?
- Have we agreed what happens after a preliminary positive, before anyone tests?
Ready to look at categories side by side? Return to the test kit guide.
Sources
- U.S. Food and Drug Administration, "Drugs of Abuse Home Use Test" (content current as of 27 September 2018; read 21 October 2026). Supports: qualitative results; preliminary positives and laboratory confirmation; interference from foods, supplements, beverages and medicines; over-the-counter medicines and amphetamine results; prescribed medicines; reasons for a wrong negative (wrong drug, timing, storage, expiry); no test of this type is 100% accurate; read instructions first; read window; the urine detection-time guideline table.
- U.S. Food and Drug Administration, "Drugs of Abuse Tests" (read 21 October 2026). Supports: FDA review of design, performance and instructions; employment/insurance-only labelling generally not reviewed; examples by setting and specimen; Class II listing; "cleared by the FDA for marketing"; same test sold under different brand names.
- U.S. Food and Drug Administration, "Drugs of Abuse (Collection Kit)" (content current as of 27 September 2018; read 21 October 2026). Supports: specimen types; time for drugs to appear; laboratory preliminary and more complete analysis.
- U.S. Food and Drug Administration, "Device Approvals and Clearances" (read 21 October 2026). Supports: definitions of 510(k) and PMA.
- U.S. Food and Drug Administration, "Overview of IVD Regulation" (read 21 October 2026). Supports: device classes; 510(k) substantial equivalence; three CLIA complexity categories.
- U.S. Food and Drug Administration, "Clinical Laboratory Improvement Amendments (CLIA)" (read 21 October 2026). Supports: roles of CMS, FDA and CDC.
- Centers for Medicare & Medicaid Services, "Clinical Laboratory Improvement Amendments (CLIA)" (read 21 October 2026). Supports: CLIA aims to ensure quality laboratory testing; CMS regulates laboratory testing on humans in the U.S.
- U.S. Food and Drug Administration, "CLIA Waiver by Application" (read 21 October 2026). Supports: definition of waived tests; Certificate of Waiver; moderate-complexity tests can apply for waiver.
- U.S. Food and Drug Administration, "CLIA Categorizations" (read 21 October 2026). Supports: tests cleared or approved for home use are categorised as waived.
- MedlinePlus, "Opioid Testing" (updated 8 December 2025; read 21 October 2026). Supports: specimen types; most opioid tests use urine; meaning of a negative; medicines and poppy seeds can show as opioids; hair and longer-term use; home positives need a follow-up laboratory test.
- CDC, MMWR, "Notes from the Field: High Prevalence of Fentanyl Detected by the Maryland Emergency Department Drug Surveillance System — Baltimore, Maryland, 2019" (12 June 2020; read 21 October 2026). Supports: the opiate screen was negative for 55% (186 of 340) of fentanyl-positive specimens.
- SAMHSA, "Workplace Drug Testing Resources" (read 21 October 2026). Supports: Medical Review Officers are licensed physicians who review laboratory results; a laboratory-confirmed positive does not automatically mean misuse.
General education only, not medical or legal advice. For questions about a particular result, speak to a healthcare professional.
Page last updated